Pfizer to Pay $430 Million Fine over Illegal Marketing

NPR | By Snigdha Prakash

Published May 13, 2004 at 12:00 AM EDT

Pfizer is fined $430 million for illegal marketing practices surrounding the drug Neurontin. The unprecedented fine comes after the company admitted that the epilepsy drug was promoted for several unapproved uses, including migraines, chronic pain and bipolar disease.

States had complained that the company's marketing practices inflated the costs of the Medicaid program for the poor. NPR's Snigdha Prakash reports.

Snigdha Prakash

Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.

SUSTAIN what matters. BUILD what’s next.

With federal funding eliminated, WKAR relies more than ever on community support to sustain essential services that remain freely available to everyone in mid-Michigan. Your support helps shape what comes next for public media in our region. The best way to support WKAR is by becoming a sustaining member today or by upgrading your current gift. Support WKAR TV Here | Support WKAR Radio Here.